NRx Pharmaceuticals, Inc. (NRXPW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 58M |
| Enterprise Value | 50.83M |
| P/E Ratio | -4.79 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 18.13 |
| Price/Book Ratio | -788.42 |
| Enterprise/Revenue | 10.64 |
| Enterprise/EBITDA | -1.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -6.92 |
| Operating Margin | -5.88 |
| Return On Assets | -0.69 |
| Return On Equity | 1.69 |
| Revenue | 1.23M |
| Revenue/Share | 0.09 |
| Gross Profit | 720,000 |
| EBITDA | -27.81M |
| Net Income | -28.62M |
| Diluted EPS | -1.34 |
| Total Cash | 26.69M |
| Total Cash/Share | 0.71 |
| Total Debt | 1.25M |
| Total Debt/Equity | -7.33 |
| Current Ratio | 0.86 |
| Book Value Per Share | -0 |
| 52-Week Change | -82.62 |
| 52-Week High | 0.16 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.06 |
| Average Volume | 20,160 |
| Shares Outstanding | 25.48M |
| % Held by Institutions | 0.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |